CD20 is a B-cell differentiation antigen and known to induce apoptosis in Burkitt's lymphoma/leukemia (BL) cells upon antibody-mediated crosslinking. We examined the biological effect of CD20 crosslinking on BL cell lines and observed that apoptosis induction is accompanied by activation of multiple caspases, including caspase-8, -9, -3, -2, and -7. Further investigation revealed a clear synergism between apoptosis mediated by CD20 and by B-cell antigen receptor (BCR). Examination of the effect of simultaneous crosslinking of other cell surface molecules with crosslinking of CD20 or BCR on apoptosis induction showed that these molecules had either a synergistic or inhibitory effect on induction of apoptosis. It is worth noting that some molecules had a different effect on CD20-and BCR-mediated apoptosis. Simultaneous crosslinking of the molecules CD10, CD22, CD72, and CD80 inhibited BCR-mediated apoptosis, but enhanced CD20-mediated apoptosis. Further studies revealed that regulation of CD20-induced apoptosis by other costimulatory molecules is achieved by modification of caspase activation. CD20-mediated apoptosis in BL cells may provide not only a model for understanding the mechanism regulating clonal selection of B cells but a new therapeutic strategy for BL patients.
Introduction
In the process of maturation, B cells proceed through multiple developmental stages that determine whether they will survive or die, changing their phenotypes in a developmental stagedependent manner. [1] [2] [3] There is no doubt that B-cell antigen receptor (BCR) is crucial for the signaling that determines the fate of B cells. In addition to BCR, however, a number of B-cell differentiation antigens have been found to mediate signal transduction that leads to proliferation and differentiation upon binding with their specific ligands and to cooperatively regulate the process of B-cell differentiation. [4] [5] [6] Thus, identifying the stimuli mediated by these surface molecules should provide an approach to understanding the molecular basis of B-cell development.
CD20 is a B-cell antigen that is expressed from the late pre-Bcell stage until being lost just prior to terminal differentiation into plasma cells, and it is thought to have a regulatory function in B-cell proliferation and differentiation. 7 A number of studies have indicated that CD20 mediates intracellular signals. [8] [9] [10] For example, CD20 is closely associated with Src-family protein tyrosine kinases (PTKs) Lyn, Fyn, and Lck, and induces activation of these PTKs upon crosslinking mediated by specific antibodies (Abs). 9 Additional signaling pathways, involving activation of PLC-g1 and PLC-g2 or activation of the mitogenactivated protein kinases (MAPKs), have been described previously. 8, 10 In addition, evidence suggests that CD20 may also be involved in the control of free calcium concentration by regulating both calcium influx and mobilization of calcium from intracellular stores. 11 More recently, crosslinking of CD20 has been shown to induce apoptosis in B cells. 12 Clinical administration of IDEC-C28, a mouse-human chimeric Ab against CD20, can induce remission of low-grade B-lineage lymphomas. 13 It was originally suggested that the main mechanisms of this action are complement-mediated and Ab-dependent cell-mediated cytotoxicity, 14 but a recent study has demonstrated that Ab-mediated crosslinking of CD20 induces apoptosis in B-lineage lymphoma cell lines, including Burkitt's lymphoma (BL) cells. 10 The fact that CD20-mediated apoptosis is inhibited either by a selective inhibitor of the Src-family PTK, PP2, or by EGTA and BAPTA, which block changes in cytoplasmic Ca 2+ , has suggested the involvement of CD20-mediated signaling events in the apoptotic process. 15, 16 Although it is unclear how the CD20-mediated signals initiate events further downstream that lead to the apoptotic process, involvement of the rapid downregulation of c-myc and upregulation of Bax, a Bcl-2-family protein, followed by activation of caspase-3 has been reported. 10, 15, 16 BL cells are also known to be induced to undergo apoptosis by activation of BCR. 17 The fact that both apoptotic processes share similar intracellular events, such as activation of MAPKs, similar changes in the expression of c-myc and Bax, and caspase-3 activation, has suggested a close correlation between CD20-and BCR-mediated apoptosis. 10 Both pathways are probably mediated in part by the same signal-transducing molecules, but the details are for the most part unknown.
In the present study, we further investigated the details of the intracellular events that occur during the process of CD20-mediated apoptosis. Our findings extend the observations of others and indicate involvement of activation of multiple caspase cascades in CD20-mediated apoptosis and show that costimulatory signals by a number of B-cell surface molecules modulate the CD20-mediated apoptotic process by affecting the caspase cascade. Although clear synergism between CD20 and BCR crosslinking on the apoptosis-inducing effect was observed, these two apoptotic signaling pathways are distinctly regulated by other costimulatory signals.
Materials and methods

Cells
BL-derived cell lines, Daudi, Ramos, Raji, P32/ISH (Japanese Cancer Research Resources Bank, Tokyo, Japan), CA-46 (Dainippon Pharmacology Co., Osaka, Japan), EB-3, and Namalwa (Institute for Fermentation, Osaka, Japan) were used. An acute lymphoblastic leukemia L3 type (ALL-L3)-derived cell line BALM-18 18 was also used. Since ALL-L3 is thought to be the leukemic form of BL and has been designated as Burkitt leukemia in the new WHO classification of tumors of hematopoietic and lymphoid tissues, 19 we include ALL-L3-derived cell lines in BL-derived cell lines in this paper for convenience. Cells were cultured in RPMI1640 supplemented with 10% fetal calf serum at 371C in a humidified 5% CO 2 atmosphere.
Reagents
The mouse monoclonal (m)Abs used for immunofluorescence study were: anti-CD20, anti-CD22, anti-CD32, anti-CD38, anti-CD40, anti-CD48, anti-CD70, anti-CD72, anti-CD80, anti-CD81, anti-CD95, and anti-CD124 from Beckman/Coulter Inc. (Westbrook, MA, USA); anti-CD55 and anti-CD59 from Pharmingen (San Diego, CA, USA); anti-CD19, anti-CD45, and anti-m heavy chain from American Type Culture Collection (Rockville, MD, USA). Anti-CD10 20 and anti-CD24 (L30) 21 were also used. The mouse mAbs used for immunobiochemical study in this paper were: anti-caspase-2, anti-caspase-3, and anti-caspase-7 from Transduction Laboratories (Lexington, KY, USA); anti-PARP from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA, USA); anti-b-actin from Seikagaku Co. (Tokyo, Japan). The rabbit polyclonal Abs used were: anticaspase-8 from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti-caspase-9 and anti-Bid from New England Biolabs, Inc. (Bevely, MA, USA). Secondary Abs, including fluoresceinand enzyme-conjugated Abs were purchased from either Jackson Laboratory, Inc. or Molecular Probes (Eugene, OR, USA). Biotinylation of mAb was performed as described previously. 20 Conjugation of Alexa Fluor s 488 to anti-CD20 mAb was performed by using Alexa Fluor s 488 Monoclonal Antibody Labeling Kit (Molecular Probes) according to the manufacturer's protocol. Conjugation of Abs to polystyrene beads was performed as described previously. 22 To crosslink cell surface antigens, cells were cultured in the presence of Abs as indicated. In these cases, Abs were dialyzed in PBS prior to addition to culture to remove additives. All chemical reagents were obtained from Sigma-Aldrich Fine Chemicals (St Louis, MO, USA), unless otherwise indicated. The peptide inhibitors of caspase used in this study were: z-Tyr-Val-Ala-Asp-fluoromethyl ketone (z-YVAD-fmk, specific for caspase-1), z-Asp-Glu-ValAsp (DEVD)-fmk (for caspase-3), z-Ile-Glu-Thr-Asp (IETD)-fmk (for caspase-8), z-Leu-Glu-His-Asp (LEHD)-fmk (for caspase-9), and z-Val-Ala-Asp (VAD)-fmk (for a broad spectrum of caspases) from Calbiochem-Novabiochem Co. (San Diego, CA, USA).
Immunofluorescence study and detection of apoptosis
To test the expression of cell surface antigens, cells were stained with FITC-labeled mAbs and analyzed by flow cytometry (EPICS-XL, Beckman/Coulter) as described previously. 20 To quantitate the incidence of apoptotic cells, cells were stained with FITC-labeled annexin-V by using a MEBCYTO s -Apoptosis Kit (Medical & Biological Laboratories, Co., LTD., MBL, Nagoya, Japan) and then analyzed by flow cytometry according to the manufacturer's protocol. Experiments were performed in triplicate, and the means7s.d.s of the cells that bound annexin-V are shown. Caspase-3 activity was assessed with a PhiPhiLUXt G1D2 kit (MBL) and analyzed by flow cytometry according to the manufacturer's protocol. To observe the extent of CD20 clustering on the cell surface, cells were stained with Alexa Fluor s 488-conjugated anti-CD20 mAb and examined by confocal microscopy (Fluoview FV500, Olympus, Co., Tokyo, Japan) using the appropriate filter set as described previously. 22 
Immunoblotting
A 50 mg quantity of each whole-cell lysate was electrophoretically separated on an SDS-polyacrylamide gel and transferred to a nitrocellulose membrane by a semidry transblot system (Bio-Rad Laboratories, Hercules, CA, USA). Immunoblotting was performed as described previously. 22 
Results
Establishment of cell line BALM-24
Peripheral blood mononuclear cells obtained from a 46-year-old female patient with ALL-L3 at diagnosis were cultured as described previously. 18 At the initiation of the culture, a mouse bone marrow stroma cell line MS-5 cells 23 were used as feeder cells. The cells began to proliferate 3 weeks after and adapted to growth in medium without feeder cells. When established, the cell line was designated BALM-24. Cytogenetic analysis of BALM-24 cells showed the t(8; 14)(q24.1; q32) chromosomal abnormality, which is highly associated with ALL-L3 and BL. Additional chromosomal abnormalities +add(1)(p?13), del(4)(q12), -13, -20, and +mar1 were observed.
Activation of caspases in the course of CD20-mediated apoptosis
First, we tested whether crosslinking of CD20 induces apoptosis in BL cells by using the newly established cell line BALM-24, which expresses CD20 (Figure 1 ). When BALM-24 cells were exposed to anti-CD20 mAb in the presence of secondary rabbit polyclonal anti-mouse Ig Ab for 24 h, more than 60% of the cells appeared to be annexin-V bound, indicating significant apoptosis induction (Figures 2a and 3a) . When we tested anti-CD20 mAb immobilized on polystyrene beads and a combination of biotinylated anti-CD20 mAb and avidin, we obtained identical results (data not shown).
Since a number of studies have indicated that caspases are essential effector molecules in the apoptotic process in various cell systems, 24 we investigated whether they are activated during the apoptotic process induced by CD20 crosslinking in BALM-24 cells. When the cell lysates prepared from CD20-crosslinked BALM-24 cells, the levels of caspase proenzyme proteins, including those of caspase-8, -9, -3, -2, and -7, decreased markedly (Figure 2b ) in parallel with the appearance of annexin-V-bound cells (Figure 2a ), indicating cleavage of the proenzymes of these caspases. Even the p20 cleaved fragment of caspase-8 was observed after CD20 crosslinking in BALM-24 cells (Figure 2b ). Immunoblot analysis also revealed cleavage of Bid, an apoptosis-related Bcl-2 family protein, and PARP, a substrate of caspases, during the course of apoptosis mediated by CD20 crosslinking in BALM-24 cells (Figure 2b ). No significant change was observed in the protein level of b-actin, indicating that the amounts of protein loaded onto each lane were comparable (Figure 2b ). We also tested the activity of caspase-3 in individual cells by PhiPhiLux TM G1D2. As shown in Figure 2c , a significant increase in fluorescence activity was observed in more than 60% of BALM-24 cells after CD20 crosslinking, indicating the activation of caspase-3 in these cells.
We then examined the enzymatic activity of caspase-3 by colorimetric assay in BALM-24 cells induced by CD20 crosslinking and exposed to the specific tetrapeptide substrate DEVDpNA. As shown in Figure 4a , a significant elevation of DEVD- To further examine the involvement of activation of the caspase cascade in the process of CD20-mediated apoptosis, we examined the effect of peptide inhibitors of the caspases. When BALM-24 cells pretreated with z-VAD-fmk (a tripeptide inhibitor of a broad range of caspases) were incubated with a combination of anti-CD20 Ab and secondary anti-mouse Ab, the number of annexin-V-positive cells was significantly reduced compared with cells not exposed to z-VAD-fmk ( Figure 4b ). When we tested the effect of z-IETD-fmk (a tetrapeptide inhibitor of caspase-8), z-LEHD-fmk (a tetrapeptide inhibitor of caspase-9), and z-DEVD-fmk (a tetrapeptide inhibitor of caspase-3), a weak reduction in annexin-V-positive cells after CD20 crosslining was observed (Figure 4b ), but it was no greater than observed with Apoptosis induction in Burkitt's lymphoma/leukemia (BL) cells mediated by crosslinking of CD20 and B-cell antigen receptor. The nine BL cell lines indicated were exposed to either (a) anti-CD20 monoclonal antibody (mAb) (aCD20, 5 mg/ml) or (b) anti-m heavy-chain mAb (am, 5 mg/ml) in the presence of secondary rabbit anti-mouse Ig Ab (RaM, 5 mg/ml) for 24 h. Apoptotic cells were detected by annexin-V assay as in Figure 2a . (c) BALM-24 cells exposed and unexposed to a suboptimal dose of aCD20 mAb (aCD20-S, 0.5 mg/ml) (columns 2 and 4) and am mAb (am-S, 0.1 mg/ml) (columns 3 and 4) for 24 h were examined as in Figure 2a .
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z-VAD-fmk. By contrast, pretreatment with z-YVAD-fmk (tetrapeptide inhibitor of caspase-1-like protease) did not cause any reduction in the number of apoptotic cells evaluated by annexin-V binding (Figure 4b ), indicating that the above peptide inhibitors specifically inhibited of CD20-mediated apoptosis of BALM-24 cells. The evidence that this apoptotic process is inhibited by specific peptide inhibitors of caspases further indicates that the activation of the caspase cascade participates in the induction of apoptosis after CD20 crosslinking.
Caspases themselves have been shown to form a regulatory cascade that transduces apoptotic signals. 25 To clarify the cascade of caspases that is activated during CD20-mediated apoptosis in BALM-24 cells, we examined the effect of peptide inhibitors on the activation of caspase-3 induced by CD20 crosslinking. Evaluation based on DEVD-pNA cleavage activity measured by colorimetric assay showed that both z-IETD-fmk and LEHD-fmk significantly inhibited the activation of caspase-3 (Figure 4a ), indicating that inhibition of caspase-8 or -9 leads to reduction of caspase-3 activation. Assessment with PhiPhiLux TM G1D2 further indicated that both z-IETD-fmk and LEHD-fmk reduced the number of cells in which caspase-3 was activated after CD20 crosslinking (Figure 4c ). These findings indicate that both caspase-8 and -9 are located upstream of caspase-3 in the cascade. It should be noted that inhibition of caspase-8 was more effective than inhibition of caspase-9 in inhibiting caspase-3 activation (Figure 4a and c).
Crosslinking of CD20 and that of BCR synergisticcally affect apoptosis induction in BL cells
Next, we compared the apoptosis-inducing effect of CD20 crosslinking in different BL cell lines. Testing for cell surface expression of CD20 in various BL cell lines showed that most of the lines expressed CD20 ( Figure 1 ). As shown in Figure 1 , flowcytometric analysis revealed high levels of expression of CD20 in seven cell lines; BALM-18, BALM-24, Daudi, EB-3, Ramos, Raji, and P32/ISH. By contrast, CA-46 and NAMALWA cells exhibited a lower level and faint expression, respectively, of CD20 ( Figure 1 ). As shown in Figure 3a , annexin-V-binding assay revealed that the magnitude of apoptosis induction after CD20 crosslinking varied considerably among the BL lines and that it is not necessarily correlated with the level of expression of CD20. For example, in spite of comparable high levels of expression of CD20 in BALM-18 and P32/ISH cell lines, the incidence of apoptosis induction was approximately 70 and 30%, respectively (Figures 1 and 3a) . On the other hand, although CA-46 cells express easily recognizable levels of CD20 (Figure 1) , crosslinking of CD20 failed to induce apoptosis in these cells at all (Figure 3a) .
Since crosslinking of BCR has also been reported to induce apoptosis in BL cells, 17 we examined the correlation between CD20 crosslinking and that of BCR on the apoptosis-inducing effect. As shown in Figure 1 , flow cytometric analysis revealed high levels of expression of BCR on all BL lines tested, with the exception of Raji cells, which express only low amounts of BCR on the cell surface. When these BL lines were examined by annexin-V-binding assay, most of the lines expressing high levels of BCR showed a higher incidence of apoptosis induction after BCR crosslinking (Figure 3b) . Interestingly, however, two lines, CA-46 and NAMALWA, which exhibited low sensitivity to CD20-mediated apoptosis, showed no significant induction of apoptosis after crosslinking of BCR either (Figure 3a and b) .
We next examined crosslinking of BCR and that of CD20 for synergism in inducing of apoptosis. Since both anti-m heavy- Effect of caspase inhibitors on CD20-induced apoptosis. (a) After 1-h pre-incubation with the peptide inhibitors of caspases indicated (20 mM each), BALM-24 cells were exposed to a combination of anti-CD20 monoclonal antibody (mAb) (aCD20, 5 mg/ml) and secondary rabbit anti-mouse Ig Ab (RaM, 5 mg/ml) for 24 h, and the subsequent caspase-3 activity was measured by colorimetric assay with the specific peptide substrate DEVD-pNA. (b) After cell preparation as in (a), the subsequent incidence of apoptotic cells was determined as in Figure 2a. (c) After cell preparation as in (a), individual cells were examined for caspase-3 activation by flow cytometry using PhiPhiLux TM GiD2. IETD for caspase-8; LEHD for caspase-9; YVAD for caspase-1; VAD for a broad spectrum of caspases; DEVD for caspase-3. (Figure 3a and b) , we employed suboptimal doses of these mAbs to be able to observe synergism clearly. When both mAbs were mixed under suboptimal conditions, clear synergism was observed between crosslinking of CD20 and that of BCR on apoptosis induction in BALM-24 cells (Figure 3c ).
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Effect of co-crosslinking of other cell surface molecules on CD20-and BCR-mediated apoptosis BALM-24 cells express various B-cell differentiation antigens on their surface, as shown in Figure 5 . We therefore investigated the effect of co-crosslinking of various cell surface molecules on both CD20-and BCR-mediated apoptosis. The cell surface molecules could be classified into several groups according to their effects. As shown in Figure 6 , the GPI-anchored proteins, CD48, CD55, CD59, and CD24, clearly enhanced both CD20-and BCR-mediated apoptosis upon simultaneous crosslinking, and other molecules, CD38 (bifunctional ectoenzyme), CD19/ CD81 (stimulatory coreceptor of BCR), CD45 (protein tyrosine phosphatase), and CD70 (CD27 ligand), also enhanced induction of apoptosis mediated by both CD20 and BCR upon simultaneous crosslinking ( Figure 6 ). It should be noted that most of these molecules induced a low incidence of apoptosis by themselves, but that no induction of apoptosis was observed by CD81 or CD45 alone. By contrast, stimulation of the inhibitory coreceptors of BCR, such as CD32, CD40, and CD124 (IL-4 receptor), which inhibit BCR-mediated apoptosis (Figure 7c ), also inhibited CD20-mediated apoptosis (Figure 7b ). Interestingly, other molecules that significantly inhibited BCRmediated apoptosis, CD80, CD10, CD22, and CD72 (Figure 7c) , enhanced CD20-mediated apoptosis upon simultaneous crosslinking (Figure 7c ). Co-crosslinking of CD95 (Fas) had no effect on either CD20-or BCR-mediated apoptosis in BALM-24 cells.
Since it was possible that the modulatory effect of other molecules varies significantly between cell lines, we similarly examined one additional cell line, P32/ISH, in which CD20 induces a low level of apoptosis. As shown in Figures 1 and 5 , flow-cytometric analysis revealed that the pattern of expression of B-cell differentiation antigens by P32/ISH was similar to that of BALM-24 cells, with some exceptions, including low-level expression of CD70, CD95, and CD124. Investigation of the effect of co-crosslinking of various cell surface molecules on both CD20-and BCR-mediated apoptosis in P32/ISH cells (Figures 6 and 7) essentially showed effects on the molecules, CD48, CD55, CD59, CD24, and CD38, similar to those in BALM-24 cells. However, the incidence of the effects was significantly different on the other molecules. For example, enhancement of CD20-mediated apoptosis by co-crosslinking of the molecules, CD19, CD81, CD45, CD70, CD80, CD10, CD22, and CD72, was less significant than observed in BALM-24 cells. Inhibition of CD20-mediated apoptosis by co-crosslinking of the molecules, CD32, CD40, and IL-4 receptor, was also less significant than observed in BALM-24 cells.
Effect of co-crosslinking of CD20 and other cell surface molecules on caspase-3 activity
Next, we investigated whether the caspase cascade is involved in the alteration of CD20-induced apoptosis mediated by cocrosslinking of other molecules. Flow-cytometric analysis with Expression of cell surface antigens on BALM-24 and P32/ISH. BALM-24 cells (left) were stained with FITC-labeled specific mAbs against B-cell differentiation antigens as indicated and analyzed by flow cytometry. The histograms obtained have been displayed as in Figure 1 . In the case of the antigens expressed at low levels CD95, CD80, and CD32, the histograms obtained were superimposed on these of the negative controls (cells stained with isotype-matched control mouse immunoglobulin, broken light lines) and displayed. P32/ISH cells (right) were examined in a similar manner. X-axis, fluorescence intensity; Y-axis, relative cell number.
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PhiPhiLux
TM G1D2 indicated that co-crosslinking of other molecules affected the numbers of cells in which caspase-3 was activated after crosslinking of CD20 ( Figure 8a ). As shown in Figure 8a , co-crosslinking of CD32 reduced the number of CD20-mediated caspase-3-activated cells, whereas co-crosslinking of CD80 increased them. Assessment by colorimetric assay with DEVD-pNA as the substrate revealed that cocrosslinking of CD32 also significantly reduced the caspase-3 activation induced by CD20 crosslinking (Figure 8b ), whereas co-crosslinking of CD80 markedly enhanced caspase-3 activation (Figure 8b ). The data indicated that simultaneous crosslinking of other molecules affects activation of caspase cascade induced by CD20 crosslinking.
Effect of co-crosslinking of CD20 and other cell surface molecules on CD20-clustering
The mechanism of enhanced apoptosis caused by co-crosslinking of CD20 and other cell surface molecules is unclear. One possibility is that the costimulation protocol we used in this study simply enhances the extent of CD20 clustering itself, thereby enhancing the apoptotic signal that emerges from CD20 clustering. To test this hypothesis, we used confocal microscopy to examine the extent of CD20 clustering after each treatment.
When BALM-24 cells were incubated with Alexa Fluor s 488-conjugated anti-CD20 mAb in the presence of non-labeled secondary rabbit anti-mouse Ab for 30 min at 371C, CD20 was found to be concentrated in distinct patches within the membrane (Figure 9 ). When either anti-CD80 or anti-CD32 mAb was added simultaneously, the extent of CD20 clustering on the cell surface did not change significantly. Thus, the results indicate that the alteration of CD20-induced apoptosis mediated by co-crosslinking of other molecules is not merely because of enhanced clustering of CD20 itself.
Effect of independent crosslinking of other cell surface molecules on CD20-mediated apoptosis
We employed the biotin-avidin system to further investigate whether crosslinking between CD20 and other cell surface molecules is necessary for the synergistic or inhibitory effect on induction of apoptosis. As shown in Figure 10 , in the presence of avidin (10 mg/ml) a suboptimal dose of biotinylated anti-CD20 mAb (5 mg/ml) induced a low level of apoptosis in BALM-24 cells. When added simultaneously, mAbs against CD19, CD70, and CD80, but not CD45, slightly, but clearly, enhanced the apoptosis induced in BALM-24 cells by a combination of biotinylated anti-CD20 mAb and avidin Figure 10 ). It should be noted that anti-CD70 induced a low incidence of apoptosis by itself without further ligation by secondary anti-mouse Ab, however, no induction of apoptosis was observed by either CD19 or CD80 alone ( Figure 10 ). By contrast, simultaneous addition of anti-CD32 mAb inhibited the apoptosis induced in BALM-24 cells by the combination of biotinylated anti-CD20 mAb and avidin ( Figure 10 ). Based on these results, it was concluded that independent crosslinking of each molecule can induce a synergistic and inhibitory effect on the CD20-induced apoptosis. However, the modulatory effect of other cell surface molecules on CD20-mediated apoptosis observed in this experiment was not as significant as that observed in Figures 6 and 7 , and independent crosslinking of CD45 had no effect on CD20-mediated apoptosis in this system. Therefore, CD20 and other molecules may need to be clustered together for some part of the modulatory action. Alternatively, some cell surface molecules, such as CD45, may need to be strongly crosslinked by the secondary reagent to exert full regulatory activity on CD20-mediated apoptosis.
CD20-induced apoptosis in
Burkitt's cells K Mimori et al (
DISCUSSION
The caspases, evolutionarily conserved cysteine proteases, have been classified into three distinct groups based on their individual substrate specificities. 26 Group I caspases, caspase-1, -4, and -5, prefer the tetrapeptide sequence WEHD, which occurs in cytokines IL-1 b and IL-18, and thus it participates in the cleavage-mediated activation of these cytokines. The group II caspases, caspase-2, -3, and -7, have optimal peptide recognition of motif DEXD and are thought to be effector proteases that destroy essential homeostatic pathways during the apoptotic process. By contrast, the members of group III, caspase-6, -8, and -9, prefer the peptide sequence recognition motif (L/V)EXD, which resembles the motif at the activation sites of effector caspase proenzymes.
In fact, caspases themselves have been shown to form a regulatory cascade. Apoptotic stimuli mediated by cell surface molecules induce activation of group III upstream caspases, which subsequently directly cleave and activate group II downstream caspases. 27 The downstream caspases go on to cleave various cellular substrates, such as PARP, fodrin, lamin, and ICAD, all of which are responsible for apoptosis. 28 Recently, however, the presence of an alternative mechanism for activation of downstream caspases by upstream caspases has been discovered. Several studies have indicated that activated caspase-8 cleaves Bid, a death agonist member of the Bcl-2/Bclx L family, which in turn induces cytochrome c release from mitochondria. 29, 30 In response to cytochrome c, caspase-9 binds to Apaf-1, the human homologue of C. elegans CED-4, becomes activated, 31, 32 and then cleaves and activates procaspase-3. A recent study by Besnault et al 33 demonstrated involvement of the caspase-8-initiated mitochondria-dependent caspase-3 activation pathway in the process of BCR-mediated apoptosis.
Although the precise mechanism of CD20 induction of apoptosis in BL cells is unknown, caspase-3 has been reported to play a crucial role in the process as an effector. 15, 16, 24 Our data, however, indicate that activation of multiple caspases is also involved in CD20-induced apoptosis in BL cells. As shown in this study, the peptide inhibitor of caspase-3 reduced CD20-induced apoptosis, but its effect was much weaker than that of z-VAD-fmk, a peptide inhibitor of a broad range of caspases, suggesting involvement of other caspases than caspase-3 as CD20-induced apoptosis in Burkitt's cells K Mimori et al effectors of the apoptotic process. Immunoblot analysis has consistently indicated activation of multiple caspases, including caspase-2, -7, -8, and -9. The current model of the regulatory cascade of caspases suggested that caspase-2 and -7, both of which are classified as group II caspases, act as effector caspases the same as caspase-3. By contrast, caspase-8 and -9 are thought to participate in activating these downstream caspases in the process of CD20-mediated apoptosis. Indeed, as we have shown in this study, the evidence that the peptide inhibitor of caspase-8 and -9 inhibited the activation of caspase-3 induced by CD20 crosslinking supports this notion. This evidence together with the evidence of cleavage of Bid indicate that mitochondriadependent activation of caspase-3 is involved in CD20-induced apoptosis. However, the effect of caspase-9 inhibitor in reducing CD20-mediated caspase-3 activation is less than that of caspase-8 inhibitor, and thus not only the mitochondria-dependent pathway but also other mechanisms, such as direct cleavage of caspase-3 by -8, may participate in the CD20-mediated activation of caspase-3. All of the above findings suggest involvement of multiple caspase cascades in the process of CD20-induced apoptosis.
In the process of B-cell differentiation, signals mediated by BCR primarily determine whether B cells survive or not, but other stimuli mediated by surface-expressing molecules coop- Effect of simultaneous crosslinking of CD32 and CD80 on CD20-and B-cell-antigen-receptor-mediated apoptosis in BALM-24 cells. (a) BALM-24 cells were exposed to a combination of anti-CD20 monoclonal antibody (mAb) (aCD20, 5 mg/ml), anti-CD32 mAb (aCD32, 5 mg/ml), and anti-CD80 mAb (aCD80, 5 mg/ml), in the presence of secondary RaM Ab (5 mg/ml) for 24 h and subsequent caspase-3 activity was measured by flow-cytometry with PhiPhiLux TM GiD2. (b) After the same treatment as in (a), subsequent caspase-3 activity was measured by colorimetric assay using specific peptide substrate DEVD-pNA.
Figure 9
CD20 clustering on BALM-24 cells after treatment with anti-CD20 mAb. To observe the extent of CD20 clustering on the cell surface, cells were incubated for 30 min at 371C with a combination of Alexa Fluor s 488-conjugated anti-CD20 (aCD20) mAb and nonlabeled anti-CD80 (aCD80) or anti-CD32 (aCD32) mAb in the presence of non-labeled secondary rabbit anti-mouse (RaM) polyclonal Ab. After intensive washing with ice-cold PBS and fixation with 3% paraformaldehyde in PBS, cells were examined by confocal microscopy. Typical results from each treatment are shown. Effect of independent crosslinking of other cell surface antigens on CD20-mediated apoptosis in BALM-24 cells. CD20 molecules expressed on BALM-24 cells were crosslinked with a combination of 5.0 mg/ml of biotin-conjugated anti-CD20 monoclonal antibody (mAb) and 10 mg/ml of avidin, as indicated. A 5.0 mg/ml dose of mAbs against CD19, CD45, CD70, CD80, and CD32 were added simultaneously as indicated. After 24-h incubation, the incidence of apoptotic cells was examined as in Figure 3 .
CD20-induced apoptosis in Burkitt's cells K Mimori et al erate in regulating this process. [2] [3] [4] [5] [6] Although the functional role of CD20 in a physiological context remains unclear, it can be argued that CD20 is a signal-transduction-related molecule. Since, as shown in this study, CD20-mediated stimuli significantly augment BCR-mediated apoptosis induction in BL cells, CD20 may participate in clonal selection of B cells as an enhancer of BCR-mediated negative signals.
Our findings clearly indicate that other cell surface molecules in addition to CD20 are involved in survival and death signaling in B cells. Based on their behavior in terms of BCR-and CD20-mediated apoptosis, cell surface molecules can be classified into several groups. First, GPI-anchored proteins, CD24, CD48, CD55, and CD59, which induce apoptosis in BL cells upon crosslinking by themselves, 22 synergistically affect both BCRand CD20-mediated apoptosis. Other molecules, CD38, 34 CD19, and CD70, exhibit behavior similar to that of GPIanchored proteins. Second, CD81 and CD45 do not induce apoptosis by themselves, but they clearly enhanced the apoptosis-inducing effect of both CD20 and BCR upon simultaneous crosslinking.
By contrast, the molecules known to mediate inhibitory signals for BCR, such as CD32, CD40, and CD124, downregulate the apoptosis induction mediated by both BCR and CD20. Since CD20 enhances BCR-mediated apoptotic signals, it is not surprising that these molecules also mediate inhibitory signals for CD20. CD72, however, which is known as an another inhibitory coreceptor for BCR, inhibits BCR-mediated apoptosis but enhances CD20-mediated apoptosis. The behavior of other molecules, CD10, CD22, and CD80, is similar to that of CD72. How these molecules affect BCR-and CD20-mediated apoptosis differently still remains unclear, our findings indicate the complexity of the crosstalk between regulatory signals for cell survival and death induced by cell surface molecules. It should also be noted that the modulatory effects of co-crosslinking of other molecules on CD20-induced apoptosis vary significantly between cell lines as we presented in this study.
It is worth noting that CD95, a Fas antigen, neither induced apoptosis by itself nor enhanced CD20-mediated apoptosis in BALM-24 cells. Since CD95 has been reported to play an important role in activation-induced cell death and elimination of autoreactive B cells, 35 our data may mean that this molecule has a role in B cells distinct from that mediated by BCR and CD20 in B cells.
Although the mechanism of enhancement of CD20-induced apoptosis mediated by co-crosslinking of other molecules is unknown, one possibility is that the co-crosslinking protocol used in this study simply enhances the extent of CD20 clustering itself, thereby enhancing the apoptotic signal that emerges from CD20 clustering. However, since the results of confocal microscopy in this study indicate that CD20 clustering is unaffected by co-crosslinking with either CD80 or CD32, the modulatory effect of other molecules is not merely because of alteration of the efficiency of CD20 clustering. Moreover, as shown in this study, independent crosslinking of CD19, CD80, and CD32 has a synergistic and inhibitory effect on CD20-mediated apoptosis, respectively. Thus, some part of the abovedescribed regulatory action on apoptosis is most likely achieved by crosstalk between the signals mediated by these molecules and by CD20. Further studies to elucidate the precise mechanism of the modulatory effect of other molecules on CD20-mediated apoptosis are now under way.
In this study, we also found that enhancement and inhibition of CD20-induced apoptosis by other costimulatory signals are accompanied by alterations of caspase activity. For example, when CD20-induced apoptosis is enhanced by co-crosslinking with CD80, caspase-3 activity is enhanced. By contrast, CD32-mediated inhibition of CD20-induced apoptosis is accompanied by a reduction of caspase-3 activation. How co-stimulation of CD20 and other molecules induces alterations of caspase activation is unknown, but our findings indicate that regulation of apoptosis induction mediated by crosstalk between costimulatory signals is achieved by modification of caspase activation.
In conclusion, the findings described above suggest that CD20-mediated apoptosis is closely correlated with that mediated by BCR, whereas these two apoptosis inducing signals are differently regulated by other co-stimulatory signals in B cells, at least in part. Although additional study is clearly necessary, investigation of CD20-mediated apoptosis and its regulation by other cell surface molecules should provide a new approach to understanding the regulation of clonal selection of B cells and to the establishment of a new therapeutic approach for BL patients. The finding of marked enhancement of apoptosis induction by simultaneous crosslinking of CD20 and other molecules, in particular, seems likely to provide a more effective strategy for Ab-mediated apoptosis induction therapy of B-cell malignancies.
